FUNDED RESEARCH

Dr Bettariga has secured >$401,900 AUD in competitive research funding as a Chief Investigator, including >$109,500 AUD as Chief Investigator-A, across national and international grants focused on exercise oncology and cancer progression. This includes support from organisations such as the Cancer Council Western Australia, the Movember Foundation, the World Cancer Research Fund, and national funding bodies in Europe. He is currently appointed as Chief Investigator A (CI-A) on two clinical trials investigating the cancer-suppressive effects of exercise in people living with cancer. He also contributes as a Co-Investigator on several national and international grants examining the impact of exercise on disease progression and survival outcomes.

 

GRANTS

  • 2026 to 2028: Cancer Symptom Trials Seeding Grant, University of Technology Sydney.

Stronger Bodies, Stronger Bonds: a Culturally Adapted Wellbeing and Social Connectedness Program for Chinese Speaking Cancer Survivors and Their Carers. Murray J. (CI-A), Hart N.H. (CI-B), Haywood D. (CI-C), Chauhan A. (CI-D), Pike A. (CI-E), Bettariga F. (CI-F)

Amount: $ 5,000.00 AUD

  • 2026 to 2028: INTense ExeRcise for surviVAL among men with Metastatic Prostate Cancer (INTERVAL – GAP4): a Multicentre, Randomised, Controlled, Phase III Study. Newton R.U. (CI-A), Gray E.S. (CI-B), Hart N.H. (CI-C), Zaenker P. (CI-D), Bettariga F. (CI-E)

Guizzi P. (CI-A), Bettariga F. (Co-Investigator)

Amount: $ 5,000,000.00 AUD

  • 2026 to 2027: Seed Funding, University of Technology Sydney.

Precision Resistance Training in Advanced Breast Cancer with Bone Metastases: A Feasibility Study. Bettariga F. (CI-A), Hart N.H. (CI-B), Haywood D. (CI-C), Murray J. (CI-D), Pike A. (CI-E)

Amount: $ 10,000.00 AUD

  • 2025 to 2026: Cancer Council Western Australia.

Cancer Suppression, Cytokine Levels and Body Composition Variation Across Prostate Cancer Stage and Treatments: The CYTOCOMP Study. Bettariga F. (CI-A), Newton R.U. (CI-B), Galvao D.A. (CI-C), Taaffe D.R. (CI-D), Kim J.S. (CI-E)

Amount: $ 34,500.00 AUD

  • 2024 to 2026: World Cancer Research Fund.

Enhancing Circulatory Myokines and Extracellular Vesicle Uptake with Targeted Exercise in Patients with Prostate Cancer: The MYEX Trial. Newton R.U. (CI-A), Clay T. (CI-B), Galvao D.A. (CI-C), Gray E.S. (CI-D), Kim J.S. (CI-E), Redfern A. (CI-F), Taaffe D.R. (CI-G), Bettariga F. (CI-H)

Amount: $ 117,000.00 AUD

  • 2023 to 2025: Higher Degree by Research Scholarship – Edith Cowan University.

Exercise-Induced Myokines and Their Effects on Breast Cancer Cells. Bettariga F. (CI-A)

Amount: $ 35,000.00 AUD

  • 2022 to 2025: Exercise Medicine Research Institute Scholarship – Edith Cowan University.

Exercise as Anti-Cancer Medicine in Breast Cancer. Bettariga F. (CI-A)

Amount: $ 30,000.00 AUD